Please login to the form below
COPD
This page shows the latest COPD news and features for those working in and with pharma, biotech and healthcare.
Detailed results for Regeneron's antibody cocktail continue to show benefit in high-risk COVID-19 outpatients
Despite increasing vaccination rates, many continue to be diagnosed with COVID-19 who could benefit from REGEN-COV due to underlying conditions like asthma or COPD that put them at higher
Latest news
-
AZ forecasts growth in 2021 after revenues surge in Q4
However, AZ did report that the pandemic had a significant impact on certain medicines, including sales of asthma/COPD treatment Pulmicort (budesonide) in China and some decreased use of infused/injectable
-
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
Prior to the COVID-19 pandemic, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its focus has now shifted to investigating SNG001’s potential in
-
Synairgen’s SNG001 advances into phase 3 COVID-19 trial
UK biotech had initially been testing drug for COPD and asthma. ... response. Initially, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its focus has now shifted to investigating SNG001’s potential in COVID-19
-
Positive COPD data for Synairgen's SNG001 supports COVID-19 programme
Interim analysis from the phase 2 trial in COPD patients with confirmed respiratory viral infection found that treatment with SNG001 improved lung antiviral responses compared to placebo. ... He added that, despite the encouraging data in COPD, this
-
Policy and public health: ML and AI in healthcare
If you smoke ten packs of cigarettes per day, you will likely suffer from emphysema or COPD or some other respiratory illness.
AZ forecasts growth in 2021 after revenues surge in Q4
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
Policy and public health: ML and AI in healthcare
More from news
Approximately 71 fully matching, plus 228 partially matching documents found.
Latest Intelligence
-
Well-funded life sciences firms are making long-term progress – and their investors are too
Up to that point, the drug was being developed to treat respiratory viral infections in patients with COPD who are at risk of experiencing exacerbations, which can be deadly and typically
-
Mapping at launch: it’s time to update the satnav
COPD. It has recently been approved by the FDA for asthma too, but our analysis focuses on UK performance. ... Example – GSK’s Trelegy: a moment-in-time snapshot. Trelegy launched in the UK for COPD at the end of 2017, with an Evidence Summary from
-
On our best behaviour
The main disease areas of focus have understandably been chronic diseases, including obesity, diabetes, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
-
Exploring the potential of eosinophils
Interestingly, Howarth explained that a proportion of patients with COPD also have eosinophilic inflammation.
-
Could formulary intelligence be your brand differentiator?
Spiolto – a LAMA/LABA combination for COPD and heir to Boehringer’s blockbuster Spiriva.
Well-funded life sciences firms are making long-term progress – and their investors are too
Mapping at launch: it’s time to update the satnav
On our best behaviour
Exploring the potential of eosinophils
More from intelligence
Approximately 0 fully matching, plus 48 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
in development for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. ... for the maintenance treatment of COPD.”.
-
Vikas Sinha joins Verona as non-executive director
A potential first-in-class treatment for chronic obstructive pulmonary disease (COPD), Verona Pharma's RPL554 is being tested as a nebulised maintenance treatment for patients with moderate to severe disease.
-
GSK's Dr Brett Haumann takes up chief medical officer role at Circassia
Most recently these saw him serve as VP and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD).
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Vikas Sinha joins Verona as non-executive director
GSK's Dr Brett Haumann takes up chief medical officer role at Circassia
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Covid-19: how is it affecting prescribing patterns?
COPD. COPD patients were discouraged from attending hospital-based clinics and almost exclusively managed in primary care during the first wave of the pandemic. ... However, the data confirms that prescribing remains primary care-led for COPD, with
-
Frontera wins at IPA Best of Health 2016
The Silver was awarded for ‘Breathing is everything’, an interactive video created for healthcare professionals that offers a live-action experience of what COPD patients go through on a daily basis.
-
Clinical trial recruitment on podcasts: is it a good idea?
There’s a whole array of podcasts about different conditions out there, from COPD to dementia.
-
Insights from patients during the COVID-19 pandemic
We carried out a survey among patients who have any one of these conditions: chronic obstructive pulmonary disorder (COPD), ulcerative colitis (UC), Crohn’s disease (CD) and idiopathic pulmonary fibrosis (IPF). ... Very few respondents were currently
-
Covid-19 drives change in long-term conditions management
A key resource in this field is myCOPD - a specialist self-care app designed and built by COPD experts, and externally peer-reviewed by leading NHS consultants.
Clinical trial recruitment on podcasts: is it a good idea?
Insights from patients during the COVID-19 pandemic
More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
-
Events Executive
-
Depending on Experience
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
-
Midweight-Senior Creative
-
Competitive Salary Offered
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Understanding the ‘real world’ starts and ends with the patient
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- CONGREGO™ IS NOW MULTI-PLATFORM
- Onyx Health Marks Record Growth with Six New Appointments
- FDA expands use of COVID-19 antibody cocktail
- New European supply deals show Pfizer and Moderna have increased COVID-19 vaccine prices
- Ipsen’s spending spree bolsters neurology pipeline
- AMICULUM® launches Cence, a new specialist publications agency
- The future of office working designed with our people in mind: ‘Work Where You Work Best’, an Evoke KYNE model
- GSK, Vir’s sotrovimab cuts hospitalisation and death risk by 79% in COVID-19 outpatients
- Biogen and Ionis post ‘encouraging’ early results for Alzheimer’s disease candidate
- Eylea set to challenge Lucentis in UK after NICE recommendation
- Onyx Health Launch Creative Studio After Record Year
- BioNTech to use mRNA technology to develop a ‘highly effective’ malaria vaccine
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- Guide
- How to embrace behavioural science principles in healthcare MR...
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
